Search: onr:"swepub:oai:DiVA.org:uu-320836" >
Motor Unit Number I...
-
Neuwirth, ChristophKantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.
(author)
Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis
- Article/chapterEnglish2017
Publisher, publication year, extent ...
-
ELSEVIER IRELAND LTD,2017
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-320836
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-320836URI
-
https://doi.org/10.1016/j.clinph.2016.11.026DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Objective: Motor Unit Number Index (MUNIX) is a quantitative neurophysiological measure that provides an index of the number of lower motor neurons supplying a muscle. It reflects the loss of motor neurons in patients with Amyotrophic Lateral Sclerosis (ALS). However, it is unclear whether MUNIX also detects motor unit loss in strong, non-wasted muscles. Methods: Three centres measured MUNIX in 49 ALS patients every three months in six different muscles (abductor pollicis brevis, abductor digiti minimi, biceps brachii, tibialis anterior, extensor digitorum brevis, abductor hallucis) on the less affected side. The decline of MUNIX in initially non-wasted, clinically strong muscles (manual muscle testing, MMT grade 5) was analysed before and after onset of weakness. Results: In 49 subjects, 151 clinically strong muscles developed weakness and were included for analysis. The average monthly relative loss of MUNIX was 5.0% before and 5.6% after onset of weakness. This rate of change was significantly higher compared to ALS functional rating scale (ALSFRS-R) and compound muscle action potential (CMAP) change over 12 months prior to the onset of muscle weakness (p = 0.024). Conclusion: MUNIX is an electrophysiological marker that detects lower motor neuron loss in ALS, before clinical weakness becomes apparent by manual muscle testing. Significance: This makes MUNIX a good biomarker candidate for disease progression and possibly pharmacodynamics responds.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Barkhaus, Paul E.Med Coll Wisconsin, Milwaukee, WI 53226 USA.
(author)
-
Burkhardt, ChristianKantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.
(author)
-
Castro, JoseUniv Lisbon, Hosp Santa Maria, Fac Med, Inst Mol Med,Dept Neurosci, P-1699 Lisbon, Portugal.
(author)
-
Czell, DavidKantonsspital Winterthur, Winterthur, Switzerland.
(author)
-
de Carvalho, MamedeUniv Lisbon, Hosp Santa Maria, Fac Med, Inst Mol Med,Dept Neurosci, P-1699 Lisbon, Portugal.;Natus Med Inc, Middleton, WI USA.
(author)
-
Nandedkar, Sanjeev
(author)
-
Stålberg, ErikUppsala universitet,Klinisk neurofysiologi(Swepub:uu)eriksb
(author)
-
Weber, MarkusKantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.;Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.
(author)
-
Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.Med Coll Wisconsin, Milwaukee, WI 53226 USA.
(creator_code:org_t)
Related titles
-
In:Clinical Neurophysiology: ELSEVIER IRELAND LTD128:3, s. 495-5001388-24571872-8952
Internet link
Find in a library
To the university's database